期刊文献+

子宫内膜癌PTEN蛋白及P53蛋白的异常表达 被引量:2

Abnormal expression of tumor suppressor genes PTEN and p53 in endomatrial cancinoma
原文传递
导出
摘要 目的探讨子宫内膜癌组织抑癌基因PTEN及p53异常表达的意义。方法采用免疫组织化学SP法检测62例子宫内膜癌、16例子宫内膜增生过长和9例正常子宫内膜组织PTEN蛋白及P53蛋白的表达情况,表达率的差异采用卡方检验。结果子宫内膜癌、子宫内膜增生过长和正常子宫内膜组的PTEN蛋白表达缺失率分别为64.52%、50%和11.11%,子宫内膜癌和子宫内膜增生过长组明显高于正常子宫内膜组(P<0.01),但前两组间差异不显著;子宫内膜癌组、子宫内膜增生过长和正常子宫内膜组的P53蛋白阳性表达率分别为46.77%、50%和55.56%,三组间无显著差异(P>0.05);PTEN蛋白表达缺失和P53蛋白阳性表达与子宫内膜癌组织分化程度无相关关系(P>0.05);在子宫内膜癌组中,PTEN蛋白表达缺失组P53蛋白阳性表达率为37.50%,显著低于PTEN阳性表达组的63.64%(P<0.05)。结论PTEN蛋白在子宫内膜癌的发生中可能起着比P53蛋白更为重要的作用。 Objective To study the significance of abnormal expression of tumor suppressor genes PTEN and p53 in endomatrial cancinoma. Methods Immunohistochemical method was used to detect the expression of PTEN and p53 in 62 cases of endomatrial carcinoma (EC) , 16 cases of endometrial hyperplasia (EH) and 9 cases of normal endometrium (NE). Results The negative expression rate of PTEN protein was 64.25% in EC and 50% in EH, significantly higher than that in NE ( 11.11% ) (p 〈 0.01 ), but there was no significant difference between EC and EH. The positive expression rates of P53 protein in EC, EH and NE were 46.77 % , 50% and 55.56% , respectively, with no significant difference among them (P 〉 0. 05 ). The deletion of protein expression and the positive expression of P53 protein were not significantly related with the differentiation of endomatrial carcinoma ( P 〉 0.05 ). The positive expression rate of P53 protein in the PTEN negative expression and positive expression groups were 37.50% and 63.64% , respectively, and the former was significantly lower than the later ( P 〈 0.05 ). Conclusion PTEN may play a more important role than P53 protein in endomatrial carcinogenesis.
出处 《中国体视学与图像分析》 2007年第1期16-19,共4页 Chinese Journal of Stereology and Image Analysis
关键词 子宫内膜癌 抑癌基因 PTEN P53 免疫组织化学 endometrial carcinoma tumor suppressor genes PTEN p53 immunohistochemistry
  • 相关文献

参考文献9

  • 1Parker S L,Tong T,Bolden S,et al.Cancer statistics[J].CA cancer J Clinl,1996,46(1):5227-5233.
  • 2Caduff RF,Svoboda Neamann SM,Johoston CM,et al.Molecular analysis in endometrium[J].Cancer,1997,81:219-227.
  • 3Nagasa S,Yamakama H,Sato S,et al.Identuficaion of a 790 kilobase of common allelic loss in chromosome 10q25-26 in human edomatrial cancer[J].Cancer Res,1997,57:1639-1633.
  • 4Waehama T,Dixon J E,The tumor suppressor,PTEN/MMAC1,dephosphorylates the lipid second messenger,phosphatidylinositor3,4,5-triphosphate[J].J Biol Chem,1998,273:13375-13382.
  • 5Tamura M,Gu J,Takino T,et al.Tumor suppressor PTEN inhibition of cell invasion,migration,and growyh:differential in volvement of focal adhesion kinase and pl30cas[J].Cancer Res,1999,59(2):442-449.
  • 6高谨,彭芝兰,王和,曹泽毅.子宫内膜癌组织中抑癌基因PTEN突变分析[J].实用癌症杂志,2001,16(6):587-590. 被引量:6
  • 7Kohler M F,Berchuck A,Davidoff A M,et al.Overexpresion and mutation of P53 in edometrial carcinoma[J].Cancer Res,1992,52:1622-1625.
  • 8朱有法,朱景旭,许敬尧.大肠腺瘤不典型增生及癌变组织中p53基因的表达及意义[J].中华病理学杂志,1996,25(5):306-306. 被引量:6
  • 9Lame D P,A death in the life of p53[J].Nature,1993,362:786-787.

二级参考文献11

  • 1Li J, Yen C,Liaw D,et al. PTEN: a putative protein tyrosine phosphatase gene mutated in human brain, breast,and prostate cancer[J ]. Science, 1997,275(3) :1943.
  • 2Maehama T,Dixion JE. The tumor suppressor,PTEN/MMAC1, dephosphorylates the lipid second messenger,phosphatidylinositol 3, 4, 5-trisphosphate [J ]. J Biol Chem, 1998,273(5): 13375.
  • 3Tamura M,Gu ],Matsumoto K,et al. Inhibition of cell migration,spreading, and focal adhesions by tumor suppressor PTEN[J]. Science, 1998,280(6): 1614.
  • 4Gu J,Tamura M, Yamada KM,et al. Tumor suppressor PTEN inhibits integrin-and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways[J]. J Cell Biol, 1998,143 (5): 1375.
  • 5Kong D, Suruki A, Zou TT, et al. PTEN is frequently mutated in primary endometrial carcinomas [J]. Nat Genet, 1997, 17(2): 143.
  • 6Risinger JI, Hayes K, Maxwell GL,et al. PTEN nutation in endometrial cancers is associated with favorable clinical and pathologic characteristics [J]. Clin Cancer Res, 1998,4 (12): 3005.
  • 7Imamura T, Arima T, Kato T,et al. Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas[J]. Int J Cancer, 1992,51(9)51:47.
  • 8Risinger J, Dent GA, Ignar-towbridge D, et al. p53 gene mutations in human endometrial carcinoma[J]. Mol Carcinog, 1992,5(4) :250.
  • 9Steck PA, Perhouse MA,Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in mutiple advanced cancers[J]. Nat Genet, 1997,15(4): 356.
  • 10Tashiro H,Blazes MS,Wu R,et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies [J ]. Cancer Res,1997,57(9) :3935.

共引文献10

同被引文献12

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部